Now that Gene therapy's promise has been shown, the industry must focus on improving the manufacturing process and bring down costs.

What if research hospitals could fully develop and process cell and gene therapies themselves?

Miguel Forte argues it’s time to fine tune the way we target solid tumors...

The gene therapy sector is booming, but can the industry address all the teething problems?

Small molecules continue to play a significant role in the development of innovative treatments.

"Biogen revitalizes hope for Alzheimer’s therapy, but their work highlights why we still need greater selectivity."

What challenges are companies facing in the post-FMD climate?

Brexit is a serious challenge for UK businesses trading with the EU.

Oncology research has come a long way over the past 30 years, but we must transform outdated practices to further improve drug discovery innovation.